ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,531,000 | -88.5% | 58,056 | -89.2% | 0.44% | -91.2% |
| Q1 2020 | $48,137,000 | -9.2% | 535,627 | -46.4% | 5.03% | +8.9% |
| Q4 2019 | $53,020,000 | -7.8% | 1,000,000 | -31.3% | 4.62% | -12.6% |
| Q3 2019 | $57,475,000 | -99.9% | 1,454,700 | +0.4% | 5.28% | -20.1% |
| Q2 2019 | $59,537,000,000 | +118261.5% | 1,449,300 | +34.2% | 6.61% | +32.7% |
| Q1 2019 | $50,301,000 | +11.4% | 1,080,113 | +4.2% | 4.98% | -12.7% |
| Q4 2018 | $45,143,000 | -14.1% | 1,036,575 | +12.9% | 5.71% | -30.3% |
| Q3 2018 | $52,524,000 | -23.7% | 917,767 | -35.3% | 8.19% | -14.2% |
| Q2 2018 | $68,811,000 | -99.6% | 1,418,200 | +206.8% | 9.54% | +255.3% |
| Q1 2018 | $18,074,000,000 | +245905.2% | 462,245 | +167.0% | 2.68% | +114.0% |
| Q4 2017 | $7,347,000 | +15.8% | 173,124 | +1.8% | 1.25% | +1.6% |
| Q3 2017 | $6,344,000 | -57.7% | 170,000 | -65.6% | 1.23% | -54.1% |
| Q2 2017 | $14,997,000 | +88.9% | 493,500 | +64.5% | 2.69% | +70.4% |
| Q1 2017 | $7,941,000 | – | 300,000 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |